Gabapentin: Dosages and Uses
Gabapentin is primarily used for neuropathic pain and epilepsy, with a recommended starting dose of 300 mg once daily, gradually increasing to 900-3600 mg/day in divided doses, with most patients requiring 1800-3600 mg/day for optimal efficacy. 1, 2
Indications
Neuropathic Pain
- Postherpetic neuralgia
- Painful diabetic neuropathy
- Other neuropathic pain syndromes
- Cancer-related neuropathic pain 3
Epilepsy
- Partial onset seizures (with or without secondary generalization)
- Adjunctive therapy for patients 12 years and older
- Can be used in children 3-11 years 2
Dosing Guidelines
For Neuropathic Pain
Initial Titration:
- Day 1: 300 mg once daily
- Day 2: 300 mg twice daily (600 mg/day)
- Day 3: 300 mg three times daily (900 mg/day) 2
Effective Dose Range:
For Epilepsy
Adults and children ≥12 years:
- Starting dose: 300 mg three times daily
- Maintenance: 300-600 mg three times daily (900-1800 mg/day)
- Doses up to 2400 mg/day well tolerated in long-term studies 2
Children 3-11 years:
- Starting dose: 10-15 mg/kg/day in three divided doses
- Maintenance dose:
- Ages 3-4: 40 mg/kg/day in three divided doses
- Ages 5-11: 25-35 mg/kg/day in three divided doses 2
Dosage Adjustment for Renal Impairment
| Creatinine Clearance (mL/min) | Total Daily Dose Range (mg/day) | Dose Regimen |
|---|---|---|
| ≥60 | 900-3600 | 300-1200 mg TID |
| >30-59 | 400-1400 | 200-700 mg BID |
| >15-29 | 200-700 | 200-700 mg QD |
| ≤15 | 100-300 | 100-300 mg QD |
Hemodialysis patients require supplemental post-dialysis doses 1, 2
Administration
- Can be taken with or without food
- Maximum time between doses should not exceed 12 hours
- If using scored tablets (600 mg or 800 mg), unused half-tablets should be used for the next dose or discarded after 28 days 2
Efficacy
- For neuropathic pain: 32-38% of patients achieve substantial pain relief (≥50% reduction) compared to 17-21% with placebo 4
- For epilepsy: Effective as adjunctive therapy for partial seizures, with responder rates (≥50% seizure reduction) of 29-44% 5
Common Side Effects
- Dizziness (19%)
- Somnolence (14%)
- Peripheral edema (7%)
- Gait disturbance (14%) 4
- Side effects are typically mild to moderate and often subside within approximately 10 days of treatment initiation 6
Monitoring and Evaluation
- Evaluate response every 2-4 weeks during dose titration
- Assess improvement in pain intensity, function, and quality of life
- Monitor for adverse effects and adjust dose accordingly 1
Special Considerations
- Elderly patients should start with lower doses and titrate more slowly
- Women of reproductive potential should receive counseling regarding contraception, as gabapentin is not recommended during pregnancy 1
- If discontinuing, taper gradually over at least 1 week to avoid withdrawal symptoms 2
Clinical Pearl
Gabapentin is often underdosed in clinical practice. While the FDA-approved dose for postherpetic neuralgia is up to 1800 mg/day, clinical evidence supports that many patients require 2400-3600 mg/day for optimal pain control. Don't hesitate to titrate to higher doses if lower doses are ineffective and the medication is well tolerated 1, 7, 6.